Literature DB >> 11086026

CD8(+) T-cell selection, function, and death in the primary immune response in vivo.

M F Callan1, C Fazou, H Yang, T Rostron, K Poon, C Hatton, A J McMichael.   

Abstract

The primary immune response to Epstein Barr virus (EBV) is characterized by striking proliferation of EBV-specific CD8(+) T cells. In this study we have investigated the clonal composition and functional properties of the cells mediating this primary response and have analyzed the mechanisms that control the downregulation of the primary response and the selection of memory cells. We show that massively expanded T-cell clones often dominate the primary antigen-specific T-cell response. Despite the enormous extent of expansion, the virus-specific T cells express high levels of intracellular perforin and are potently cytotoxic. They are, however, functionally heterogeneous in their ability to secrete proinflammatory cytokines, with subpopulations of the antigen-specific T cells being hyporesponsive. The primary response is closely regulated, and the majority of cells are programmed to die via a cytokine-rescuable pathway, leaving only small populations of memory T cells surviving. Comparison of the clonal composition of primary and memory responses in vivo shows that the clones that dominate the primary response are relatively heavily culled during the downregulation of the primary response and the establishment of T-cell memory.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11086026      PMCID: PMC381436          DOI: 10.1172/JCI10590

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

1.  Antigen-specific development of primary and memory T cells in vivo.

Authors:  M G McHeyzer-Williams; M M Davis
Journal:  Science       Date:  1995-04-07       Impact factor: 47.728

2.  Distinct costimulatory molecules are required for the induction of effector and memory cytotoxic T lymphocytes.

Authors:  Y Liu; R H Wenger; M Zhao; P J Nielsen
Journal:  J Exp Med       Date:  1997-01-20       Impact factor: 14.307

3.  Identification and characterization of a new member of the TNF family that induces apoptosis.

Authors:  S R Wiley; K Schooley; P J Smolak; W S Din; C P Huang; J K Nicholl; G R Sutherland; T D Smith; C Rauch; C A Smith
Journal:  Immunity       Date:  1995-12       Impact factor: 31.745

4.  Homeostatic regulation of CD8+ T cells after antigen challenge in the absence of Fas (CD95).

Authors:  C Zimmermann; M Rawiel; C Blaser; M Kaufmann; H Pircher
Journal:  Eur J Immunol       Date:  1996-12       Impact factor: 5.532

5.  Single-cell PCR analysis of TCR repertoires selected by antigen in vivo: a high magnitude CD8 response is comprised of very few clones.

Authors:  J L Maryanski; C V Jongeneel; P Bucher; J L Casanova; P R Walker
Journal:  Immunity       Date:  1996-01       Impact factor: 31.745

6.  Growth factors can enhance lymphocyte survival without committing the cell to undergo cell division.

Authors:  L H Boise; A J Minn; C H June; T Lindsten; C B Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

7.  Induction of apoptosis in mature T cells by tumour necrosis factor.

Authors:  L Zheng; G Fisher; R E Miller; J Peschon; D H Lynch; M J Lenardo
Journal:  Nature       Date:  1995-09-28       Impact factor: 49.962

8.  Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression.

Authors:  A N Akbar; N J Borthwick; R G Wickremasinghe; P Panayoitidis; D Pilling; M Bofill; S Krajewski; J C Reed; M Salmon
Journal:  Eur J Immunol       Date:  1996-02       Impact factor: 5.532

9.  T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis.

Authors:  E Scotet; J David-Ameline; M A Peyrat; A Moreau-Aubry; D Pinczon; A Lim; J Even; G Semana; J M Berthelot; R Breathnach; M Bonneville; E Houssaint
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

10.  Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory.

Authors:  N M Steven; A M Leese; N E Annels; S P Lee; A B Rickinson
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

View more
  48 in total

1.  Ex vivo analysis of phenotype and TCR usage in relation to CD45 isoform expression on cytomegalovirus-specific CD8+ T lymphocytes.

Authors:  A L Vargas; F Lechner; M Kantzanou; R E Phillips; P Klenerman
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

2.  Altered naive CD4 and CD8 T cell homeostasis in patients with relapsing-remitting multiple sclerosis: thymic versus peripheral (non-thymic) mechanisms.

Authors:  D A Duszczyszyn; J D Beck; J Antel; A Bar-Or; Y Lapierre; V Gadag; D G Haegert
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

3.  Memory generation and maintenance of CD8+ T cell function during viral persistence.

Authors:  Stephanie S Cush; Kathleen M Anderson; David H Ravneberg; Janet L Weslow-Schmidt; Emilio Flaño
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

4.  Detailed analysis of Epstein-Barr virus-specific CD4+ and CD8+ T cell responses during infectious mononucleosis.

Authors:  J Scherrenburg; E R W A N Piriou; N M Nanlohy; D van Baarle
Journal:  Clin Exp Immunol       Date:  2008-06-28       Impact factor: 4.330

5.  Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes.

Authors:  Mark E Dudley; John R Wunderlich; Paul F Robbins; James C Yang; Patrick Hwu; Douglas J Schwartzentruber; Suzanne L Topalian; Richard Sherry; Nicholas P Restifo; Amy M Hubicki; Michael R Robinson; Mark Raffeld; Paul Duray; Claudia A Seipp; Linda Rogers-Freezer; Kathleen E Morton; Sharon A Mavroukakis; Donald E White; Steven A Rosenberg
Journal:  Science       Date:  2002-09-19       Impact factor: 47.728

6.  Protective antigen-independent CD8 T cell memory is maintained during {gamma}-herpesvirus persistence.

Authors:  Stephanie S Cush; Emilio Flaño
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

7.  Impaired hepatitis C virus (HCV)-specific effector CD8+ T cells undergo massive apoptosis in the peripheral blood during acute HCV infection and in the liver during the chronic phase of infection.

Authors:  Henry Radziewicz; Chris C Ibegbu; Huiming Hon; Melissa K Osborn; Kamil Obideen; Mohammad Wehbi; Gordon J Freeman; Jeffrey L Lennox; Kimberly A Workowski; Holly L Hanson; Arash Grakoui
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

8.  Cytolytic mechanisms and T-cell receptor Vbeta usage by ex vivo generated Epstein-Barr virus-specific cytotoxic T lymphocytes.

Authors:  Victoria J Vanhoutte; Karen A McAulay; Erin McCarrell; Marc Turner; Dorothy H Crawford; Tanzina Haque
Journal:  Immunology       Date:  2009-08       Impact factor: 7.397

9.  Upregulation of interleukin 7 receptor alpha and programmed death 1 marks an epitope-specific CD8+ T-cell response that disappears following primary Epstein-Barr virus infection.

Authors:  Delphine Sauce; Martin Larsen; Rachel J M Abbott; Andrew D Hislop; Alison M Leese; Naeem Khan; Laura Papagno; Gordon J Freeman; Alan B Rickinson
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

10.  Functional and phenotypic changes in circulating lymphocytes from hospitalized zambian children with measles.

Authors:  Judith J Ryon; William J Moss; Mwaka Monze; Diane E Griffin
Journal:  Clin Diagn Lab Immunol       Date:  2002-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.